TITLE

COMMENTARY: Lipid-lowering reduce cardiovascular events in type 2 diabetes

AUTHOR(S)
Gami, Apoor S.
PUB. DATE
November 2004
SOURCE
ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a commentary on the study, which concluded that lipid-lowering reduce cardiovascular events in type 2 diabetes. Recent guidelines recommended lipid-lowering therapy for all patients with diabetes. However, direct evidence to support this recommendation was lacking [2]. The study in question incorporated the latest data (some unpublished) in this meta-analysis and provides new and important insights into the role of lipid-lowering agents in these patients. The meta-analysis is well designed but lacks assessment of publication bias, quality assessments of trials, and adequate subgroup analyses to test explanations for between-trial differences.
ACCESSION #
15303581

 

Related Articles

  • Review: Lipid-lowering reduce cardiovascular events in type 2 diabetes.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p65 

    The article addresses the question whether in patients with type 2 diabetes mellitus, lipid-lowering agents reduce cardiovascular disease (CVD) events. To find out the answer, randomized controlled trials (RCTs) of lipid-lowering agents that evaluated major CVD events in patients with type 2...

  • GP Registrar: Keeping cholesterol down. Newson, Louise // GP: General Practitioner;4/15/2005, p78 

    The article reports that in Great Britain it is estimated that cholesterol levels greater than 5.2 mmol/l are a contributory factor in 46 per cent of CHD deaths. Overwhelming evidence suggests statins are highly beneficial for both primary and secondary prevention of CHD. Target cholesterol...

  • GPs' confusion over aspirin means diabetics miss out. Pedder, Cato // Pulse;12/6/2004, Vol. 64 Issue 48, p18 

    This article focuses on primary prevention of cardiovascular disease. More than a third of diabetes patients at high risk of cardiovascular disease are not being treated according to current guidance as GPs admit to confusion over who should receive low-dose aspirin. Some 51 per cent of patients...

  • International Scientific Forum on Alcohol Research Critique 136: Alcohol's Effects on Cardiovascular Risk among Subjects with Diabetes Mellitus.  // Aroq - Just-Drinks.com (Global News);3/22/2014, p5 

    The article focuses on a study that investigates the effects of alcohol use in diabetes and cardiovascular diseases (CVD). It discusses several facts which includes variety of potential mechanisms of protection against CVD, beneficial effects of moderate drinking on lipids, inflammatory markers,...

  • Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. Jayawardena, Ranil; Ranasinghe, Priyanga; Byrne, Nuala M.; Soares, Mario J.; Katulanda, Prasad; Hills, Andrew P. // BMC Public Health;2012, Vol. 12 Issue 1, p380 

    Background: Diabetes mellitus has reached epidemic proportions worldwide. South Asians are known to have an increased predisposition for diabetes which has become an important health concern in the region. We discuss the prevalence of pre-diabetes and diabetes in South Asia and explore the...

  • Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis. Noto, Hiroshi; Goto, Atsushi; Tsujimoto, Tetsuro; Noda, Mitsuhiko // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: A growing body of evidence has suggested that metformin potentially reduces the risk of cancer. Our objective was to enhance the precision of estimates of the effect of metformin on the risk of any-site and site-specific cancers in patients with diabetes. Methods/Principal Findings:...

  • Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis. Noto, Hiroshi; Goto, Atsushi; Tsujimoto, Tetsuro; Noda, Mitsuhiko // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: A growing body of evidence has suggested that metformin potentially reduces the risk of cancer. Our objective was to enhance the precision of estimates of the effect of metformin on the risk of any-site and site-specific cancers in patients with diabetes. Methods/Principal Findings:...

  • The Frequency of Adverse Prognostic Features Detected with Ambulatory Blood Pressure Monitoring in the Practice of a Preventive Ambulatory System from Tîrgu MureÅŸ. Preg, Z.; Kikeli, P.; Márta, Germán-Salló; Mihaela, Hubatsch; Andreea-Elena, Bocicor; László, M. I. // Acta Medica Marisiensis;2012, Vol. 58 Issue 5, p324 

    Background: Twenty four hour ambulatory blood pressure monitoring (24-H ABPM) plays an important role in the management of hypertensive patients. The aim of our study was to determine the frequency of seven known adverse prognostic features in an ambulatory assisted hypertensive patient...

  • GP Registrar: MRCCP Exam Update - Diabetes and cholesterol. Newson, Louise // GP: General Practitioner;6/10/2005, p81 

    The article reports that patients with type-2 diabetes should be considered as chronic diseases (CHD) risk equivalents and dyslipidaemia should be a key therapeutic target, irrespective of baseline LDL cholesterol levels or age. Many studies have established statins as effective agents in the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics